In the present study, the administration of a HFD during pregnancy led to decreased expression of Pparα in foetal livers, possibly by inhibiting the demethylation of Pparα‐dependent fatty acid oxidation–related genes and ultimately inhibiting lipid catabolism and inducing obesity. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.